| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Seegnal Inc. Announces Resignation of CEO, Signs Five-Year Agreement to Deploy its Medication Safety Platform Across Hadassah Medical Center and Announces Aggregate US$300,000 Short Term Loans from Major Shareholders | 3 | CNW | ||
| 30.10. | Seegnal terminates older non-brokered private placements, launches new offering | 1 | Seeking Alpha | ||
| 30.10. | Seegnal Inc: Seegnal ends placement, starts $1.5M offering | 1 | Stockwatch | ||
| 30.10. | Seegnal Inc. Announces the Termination of its Non-Brokered Private Placement and New Non-Brokered Private Placement | 1 | CNW | ||
| 21.10. | Seegnal Inc: Seegnal completes installation within Israeli division | 1 | Stockwatch | ||
| 20.10. | Seegnal Completes Initial Installation Within Israel's Ministry of Health, Marking Major Operational Milestone | 2 | CNW | ||
| SEEGNAL Aktie jetzt für 0€ handeln | |||||
| 02.10. | Seegnal Inc: Seegnal extends private placement | 2 | Stockwatch | ||
| 01.10. | Seegnal Inc. Announces Extension of its Non-Brokered Private Placement | 1 | CNW | ||
| 22.09. | Seegnal Inc: Seegnal's IR deal with CapitaLynx to conclude Sept. 26 | 2 | Stockwatch | ||
| 22.09. | Seegnal Inc. Announces Conclusion of Services Agreement | 1 | GlobeNewswire (USA) | ||
| 01.09. | Seegnal Q2 non-GAAP EPS of -$0.02, revenue of $0.35M | 1 | Seeking Alpha | ||
| 27.08. | Seegnal Inc: Seegnal closes first tranche, increases placement | 1 | Stockwatch | ||
| 27.08. | Seegnal Inc. Announces Closing of First Tranche and Upsize and Extension of Private Placement | 1 | GlobeNewswire (USA) | ||
| 22.07. | Seegnal Inc: Seegnal extends private placement | 1 | Stockwatch | ||
| 10.07. | Seegnal Inc: Seegnal lists shares on Frankfurt Stock Exchange | 1 | Stockwatch | ||
| 10.07. | Seegnal Inc.: Seegnal Announces Listing on the Frankfurt Stock Exchange | 1.045 | GlobeNewswire (Europe) | CALGARY, AB, July 10, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a developer of innovative healthcare technology focused on mitigating medication risks, today... ► Artikel lesen | |
| 10.07. | XFRA NEW INSTRUMENTS AVAILABLE ON 10.07.2026 | 503 | Xetra Newsboard | The following instruments on XETRA do have their first trading 10.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.07.2026
Aktien
1 CA03771W1005 Apollo Global Management... ► Artikel lesen | |
| 26.06. | Seegnal Inc: Seegnal expands medication safety system in Israel | 2 | Stockwatch | ||
| 25.06. | Seegnal Inc.: Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint | 1 | GlobeNewswire (USA) | ||
| 19.06. | Seegnal Inc: Seegnal initiates first U.S. pilot program | 1 | Stockwatch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 59,86 | 0,00 % | HeartFlow Q3 2026 Earnings Preview | ||
| BRIGHTSPRING HEALTH SERVICES | 71,46 | 0,00 % | BrightSpring, Centene stand out as healthcare's most persistent Strong Buys | ||
| AVEANNA HEALTHCARE | 12,225 | -6,61 % | Aveanna outlines 2026 revenue >$2.695B and adjusted EBITDA >$374M as preferred payer strategy expands | ||
| LIFESTANCE HEALTH GROUP | 14,150 | 0,00 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| GENEDX | 51,89 | -5,37 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences:... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 3,720 | 0,00 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 | ||
| ADAPTHEALTH | 7,880 | +1,03 % | AdaptHealth auf der UBS Global Healthcare Conference: Trendwende bei Kaiser Permanente leitet Konsolidierungsphase ein | ||
| PHAOS TECHNOLOGY | 2,980 | 0,00 % | Phaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split | SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), ("Phaos" or "the Company"), an advanced microscopy solutions headquartered in Singapore... ► Artikel lesen | |
| OPTIMIZERX | 8,600 | 0,00 % | Stifel senkt Kursziel für OptimizeRx nach Umsatzrückgang auf 11 Dollar | ||
| CLEARPOINT NEURO | 8,475 | 0,00 % | ClearPoint Neuro: Operatives Momentum, neue Partnerschaften und Turnaround-Hoffnung für Spezialanbieter im Neuro-Markt | ClearPoint Neuro gewinnt an operativem Momentum: Das Unternehmen verzeichnet wachsendes Interesse in mehreren Geschäftssparten, treibt die Kommerzialisierung seiner Technologieplattform voran und positioniert... ► Artikel lesen | |
| GUARDIAN PHARMACY SERVICES | 49,430 | -1,04 % | Guardian Pharmacy forecasts $1.44B-$1.46B 2026 revenue and $136M-$138M adjusted EBITDA as it expands in Texas and Alabama | ||
| AGILON HEALTH | 110,46 | -3,77 % | StoneX raises agilon health stock price target to $145 on guidance | ||
| ARDENT HEALTH | 17,665 | 0,00 % | Ardent Health to buy Boone Health for purchase price of $47M in cash | ||
| MIMEDX | 3,235 | -4,01 % | MiMedx Group, Inc: MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL Regulatory Classification Matter | Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product Order Further Holds That Minimal-Manipulation Analysis Must Consider Tissue... ► Artikel lesen | |
| QTREX QUANTUM | 1,185 | 0,00 % | QTREX Quantum Ltd.: QTREX Quantum Reaffirms October 1 Disclosure and Expects Multiple Additional Commercial Agreements in the Fourth Quarter of 2026 |